浅谈我国创新药企业对外授权交易

Discussion on Out-licensing Transactions by Innovative Pharmaceutical Companies in China

对外授权交易是跨境交易的一种形式,我国创新药企业通过对外授权交易方式与海外企业合作,实现产品出海,这不仅是我国药企创新能力的体现,也为我国药企国际化发展提供帮助。近年来,我国创新药企业对外授权交易数量快速增长,本文重点分析对外授权交易市场的形成原因和发展现状,总结对外授权交易带来的收益以及面临的挑战,并为企业持久发展提供建议。

Out-licensing transactions represent a form of cross-border trade.Chinese innovative pharmaceutical companies collaborate with overseas enterprises through such transactions to bring their products to international markets.This not only showcases the innovative capabilities of Chinese pharmaceutical companies but also aids in their internationalization development.In recent years,the number of out-licensing transactions by Chinese innovative pharmaceutical companies has surged.This article primarily analyzes the reasons behind the emergence of out-licensing markets and their current state.Furthermore,it summarizes the benefits and challenges associated with such transactions and provides recommendations for long-term business growth.